Regulation of muscle mass by myostatin

Annual Review of Cell and Developmental Biology

Volumn 20, Issue , 2004, Pages 61-86

  Lee, Se Jin ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chalone; Latency; Myoblast; Satellite cell; TGF family

Indexed keywords

GROWTH INHIBITOR; MYOSTATIN; TRANSFORMING GROWTH FACTOR BETA;

CARBOXY TERMINAL SEQUENCE; EMBRYO DEVELOPMENT; HUMAN; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE GROWTH; MYOTOME; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PEPTIDE SYNTHESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SATELLITE CELL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TISSUE REACTION;

ANIMALS; MUSCLE, SKELETAL; MUSCULAR DISEASES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 8444243360     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.cellbio.20.012103.135836     Document Type: Review

References (127)

1. Akiyoshi S, Inoue H, Hanai J-i, Kusanagi K, Nemoto N, et al. 1999. c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with smads. J. Biol. Chem. 274:35269-77
2. Amthor H, Christ B, Rashid-Doubell F, Kemp CF, Lang E, Patel K. 2002a. Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth. Dev. Biol. 243:115-27
3. Amthor H, Connolly D, Patel K, Brand-Saberi B, Wilkinson DG, et al. 1996. The expression and regulation of follistatin and a follistatin-like gene during avian somite compartmentalization and myogenesis. Dev. Biol. 178:343-62
4. Amthor H, Huang R, McKinnell I, Christ B, Kambadur R, et al. 2002b. The regulation and action of myostatin as a negative regulator of muscle development during avian embryogenesis. Dev. Biol. 251:241-57
5. Armand A-S, Gaspera BD, Launay T, Charbonnier F, Gallien CL, Chanoine C. 2003. Expression and neural control of follistatin versus myostatin genes during regeneration of mouse soleus. Dev. Dyn. 227:256-65
6. Attisano L, Cárcamo J, Ventura F, Weis FMB, Massagué J, Wrana JL. 1993. Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75:671-80
7. Berk M, Desai S, Heyman HC, Colmenares C. 1997. Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial patterning, and skeletal muscle development. Genes Dev. 11:2029-39
8. Bischoff R. 1994. The satellite cell and muscle regeneration. In Myology: Basic and Clinical, ed. A Engel, C Franzini-Armstrong, pp. 97-118. New York: McGraw-Hill
9. Black K, Garrett IR, Mundy GR. 1991. Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice. Endocrine 128:2657-59
10. Blader P, Rastegar S, Fischer N, Strahle U. 1997. Cleavage of the BMP-4 antagonist chordin by zebrafish tolloid. Science 278:1937-10
11. Bogdanovich S, Krag TOB, Barton ER, Morris LD, Whittemore L-A, et al. 2002. Functional improvement of dystrophic muscle by myostatin blockade. Nature 420:418-21
12. Brill KT, Weltman AL, Gentili A, Patrie JT, Fryburg DA, et al. 2002. Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men. J Clin. Endocrinol. Metab. 87:5649-57
13. Bullough WS. 1962. The control of mitotic activity in adult mammalian tissues. Biol. Rev. 37:307-42
14. Bullough WS. 1965. Mitotic and functional homeostasis: a speculative review. Cancer Res. 25:1683-727
15. Campion D. 1984. The muscle satellite cell: a review. Intl. Rev. Cytol. 87:225-51
16. Cappucio I, Marchitelli C, Serracchioli A, Nardone A, Filippini F, et al. 1998. A G-T transversion introduces a stop codon at the mh locus in hypertrophic Marchigiana beef subjects. Anim. Genet. 29:51
17. Carlson CJ, Booth FW, Gordon SE. 1999. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am. J. Physiol. Regul. Integr. Comp. Physiol. 277:R601-6
18. Charlier C, Coppieters W, Farnir F, Grobet L, Leroy PL, et al. 1995. The mh gene causing double-muscling in cattle maps to bovine chromosome 2. Mamm. Genome 6:788-92
19. Chauvigné F, Gabillard JC, Weil C, Rescan PY. 2003. Effect of refeeding on IGFI, IG-FII, IGF receptors, FGF2, FGF6, and myostatin mRNA expression in rainbow trout myotomal muscle. Gen. Comp. Endocrinol. 132:209-15
20. Cheng SK, Olale F, Bennett JT, Brivanlou AH, Schier AF. 2003. EGF-CFC proteins are essential coreceptors for the TGF-β signals Vg1 and GDF1. Genes Dev. 17:31-36
21. Daopin S, Piez KA, Ogawa Y, Davies DR. 1992. Crystal structure of transforming growth factor-β2: an unusual fold for the superfamily. Science 257:369-73
22. de Winter JP, ten Dijke P, de Vries CJM, van Achterberg TAE, Sugino H, et al. 1996. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors. Mol. Cell. Endocrin. 116:105-14
23. Eigenbrot C, Gerber N. 1997. X-ray structure of glial cell-derived neurotrophic factor at 1.9 Å resolution and implications for receptor binding. Nat. Struct. Biol. 4:435-38
24. Esquela AF, Lee S-J. 2003. Regulation of metanephric kidney development by growth/differentiation factor 11. Dev. Biol. 257:356-70
25. Fainsod A, Deißler K, Yelin R, Marom K, Epstein M, et al. 1997. The dorsalizing and neural inducing gene follistatin is an antagonist of BMP-4. Mech. Dev. 63:39-50
26. Gamer LW, Wolfman NM, Celeste AJ, Hattersley G, Hewick R, Rosen V. 1999. A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm i nducer in Xenopus embryos. Dev. Biol. 208:222-32
27. Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, Sinha-Hikim I, Ma K, et al. 1998. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc. Natl. Acad. Sci. USA 95:14938-43
28. Griffith DL, Keck PC, Sampath TK, Rueger DC, Carlson WD. 1996. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor β superfamily. Proc. Natl. Acad. Sci. USA 93:878-83
29. Grobet L, Martin LJR, Poncelet D, Pirottin D, Brouwers B, et al. 1997. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat. Genet. 17:71-74
30. Grobet L, Poncelet D, Royo LJ, Brouwers B, Pirottin D, et al. 1998. Molecular definition of an allelic series of mutations disrupting the myostatin function and causing double-muscling in cattle. Mamm. Genome 9:210-13
31. Hansel R, Michaux C. 1985. On the genetic determinism of muscular hypertrophy in the Belgian White and Blue cattle breed. I. Experimental data. Genet. Sel. Evol. 17:359-68
32. Hayette S, Gadoux M, Martel S, Bertrand S, Tigaud I, et al. 1998. FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders. Oncogene 16:2949-54
33. Hepple RT. 2003. Sarcopenia - a critical perspective. Sci. Aging Knowl. Environ. 2003:pe31-37
34. Hill JJ, Davies MV, Pearson AA, Wang JH, Hewick RM, et al. 2002. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J. Biol. Chem. 277:40735-41
35. Hill JJ, Qiu Y, Hewick RM, Wolfman NM. 2003. Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. Mol. Endocrinol. 17:1144-54
36. Hinck AP, Archer SJ, Qian SW, Roberts AB, Sporn MB, et al. 1996. Transforming growth factor β1: three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor β2. Biochemistry 35:8517-34
37. Huet C, Li Z-F, Liu H-Z, Black RA, Galliano M-F, Engvall E. 2001. Skeletal muscle cell hypertrophy induced by inhibitors of metalloproteases; myostatin as a potential mediator. Am. J. Physiol. Cell Physiol. 281:C1624-34
38. Iemura S-I, Yamamoto TS, Takagi C, Uchiyama H, Natsume T, et al. 1998. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc. Natl. Acad. Sci. USA 95:9337-42
39. Jeanplong F, Bass JJ, Smith HK, Kirk SP, Kambadur R, et al. 2003. Prolonged underfeeding of sheep increases myostatin and myogenic regulatory factor Myf-5 in skeletal muscle while IGF-I and myogenin are repressed. J. Endocrinol. 176:425-37
40. Ji S, Losinski RL, Cornelius SG, Frank GR, Willis GM, et al. 1998. Myostatin expression in porcine tissues: tissue specificity and developmental and postnatal regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 275:R1265-73
41. Joulia D, Bernardi H, Garandel V, Rabenoelina F, Vernus B, Cabello G. 2003. Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp. Cell Res. 286:263-75
42. Kambadur R, Sharma M, Smith TPL, Bass JJ. 1997. Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res. 7:910-15
43. Kawada S, Tachi C, Ishii N. 2001. Content and localization of myostatin in mouse skeletal muscles during aging, mechanical unloading and reloading. J. Muscle. Res. Cell Motil. 22:627-33
44. Kim HS, Liang L, Dean RG, Hausman DB, Hartzell DL, Baile CA. 2001. Inhibition of preadipocyte differentiation by myostatin treatment in 3T3-L1 cultures. Biochem. Biophys. Res. Commun. 281:902-6
45. Kirsch T, Sebald W, Dreyer MK. 2000. Crystal structure of the BMP-2-BRIA ectodomain complex. Nat. Struct. Biol. 7:492-96
46. Kocabas AM, Kucuktas H, Dunham RA, Liu Z. 2002. Molecular characterization and differential expression of the myostatin gene in channel catfish (Ictalurus punctatus). Biochim. Biophys. Acta 1575:99-107
47. Kocamis H, Gahr SA, Richter J, Kirkpatrick-Keller DC, Killefer J. 2002. Myostatin and TGF-β2 gene expression patterns in response to in ovo administration of rhIGF-I during chicken embryonic development. Growth Dev. Aging 66:3-10
48. Lalani R, Bhasin S, Byhower F, Tarnuzzer R, Grant M, et al. 2000. Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight. J. Endocrinol. 167:417-28
49. Lang CH, Silvis C, Nystrom G, Frost RA. 2001. Regulation of myostatin by glucocorticoids after thermal injury. FASEB J. 15:1807-9
50. Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R. 2002. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J. Biol. Chem. 277:49831-40
51. Lee S-J, McPherron AC. 2001. Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. USA 98:9306-11
52. Lewis KA, Gray PC, Blount AL, MacConnell LA, Wiater E, et al. 2000. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 404:411-14
53. Lin J, Arnold HB, Della-Fera MA, Azain MJ, Hartzell DL, Baile CA. 2002. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem. Biophys. Res. Commun. 291:701-6
54. Liu W, Thomas SG, Asa S, Gonzalez-Cadavid N, Bhasin S, Ezzat S. 2003. Myostatin is a skeletal muscle target of growth hormone anabolic action. J. Clin. Endocrinol. Metab. 88:5490-95
55. Luo K, Stroschein SL, Wang W, Chen D, Martens E, et al. 1999. The Ski oncoprotein interacts with the Smad proteins to repress TGFβ signaling. Genes Dev. 13:2196-206
56. Ma K, Mallidis C, Artaza J, Taylor W, Gonzalez-Cadavid N, Bhasin S. 2001. Characterization of 5′-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am. J. Physiol. Endocrinol. Metab. 281: E1128-36
57. Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, et al. 2003. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am. J. Physiol. Endocrinol. Metab. 285:E363-71
58. Maccatrozzo L, Bargelloni L, Cardazzo B, Rizzo G, Patarnello T. 2001. A novel second myostatin gene is present in teleost fish. FEBS Lett. 509:36-40
59. Marcell TJ, Harman SM, Urban RJ, Metz DD, Rodgers BD, Blackman MR. 2001. Comparison of GH, IGF-I, and testosterone with mRNA of receptors and myostatin in skeletal muscle in older men. Am. J. Physiol. Endocrinol. Metab. 281:E1159-64
60. Marchitelli C, Savarese MC, Crisà A, Nardone A, Marsan PA, Valentini A. 2003. Double muscling in Marchigiana beef breed is caused by a stop codon in the third exon of myostatin gene. Mamm. Genome 14:392-95
61. Marques G, Musacchio M, Shimell MJ, Wunnenberg-Stapleton K, Cho KW, O'Conner MB. 1997. Production of a DPP activity gradient in the early Drosophila embryo through the opposing actions of the SOG and TLD proteins. Cell 91:417-26
62. Massagué J. 1998. TGF-β signal transduction. Annu. Rev. Biochem. 67:753-91
63. Matzuk MM, Lu N, Vogel H, Sellheyer K, Roop DR, Bradley A. 1995. Multiple defects and perinatal death in mice deficient in follistatin. Nature 374:360-63
64. McCroskery S, Thomas M, Maxwell L, Sharma M, Kambadur R. 2003. Myostatin negatively regulates satellite cell activation and self-renewal. J. Cell Biol. 162:1135-47
65. McPherron AC, Lawler AM, Lee S-J. 1997. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 387:83-90
66. McPherron AC, Lawler AM, Lee S-J. 1999. Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nat. Genet. 22:260-64
67. McPherron AC, Lee S-J. 1997. Double muscling in cattle due to mutations in the myostatin gene. Proc. Natl. Acad. Sci. USA 94:12457-61
68. McPherron AC, Lee S-J. 2002. Suppression of body fat accumulation in myostatin-deficient mice. J. Clin. Invest. 109:595-601
69. Mendler L, Zador E, Ver Heyen M, Dux L, Wuytack F. 2000. Myostatin levels in regenerating rat muscles and in myogenic cell cultures. J. Muscle Res. Cell Motil. 21:551-63
70. Menissier F. 1982. Present state of knowledge about the genetic determination of muscular hypertrophy or the double muscled trait in cattle. In Muscle Hypertrophy of Genetic Origin and Its Use to Improve Beef Production, ed. JWB King, F Mennisier, pp. 387-428. The Hague: Nijhoff
71. Mittl PR, Priestle JP, Cox DA, McMaster G, Cerletti N, Grutter MG. 1996. The crystal structure of TGF-β3 and comparison to TGF-β2: implications for receptor binding. Protein Sci. 5:1261-71
72. Miyazono K, Hellman U, Wernstedt C, Heldin CH. 1988. Latent high molecular weight complex of transforming growth factor β1. Purification from platelets and structural characterization. J. Biol. Chem. 263:6407-15
73. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H. 1990. Activin-binding protein fromrat ovary is follistatin. Science 247:836-38
74. Nakashima M, Toyono T, Akamine A, Joyner A. 1999. Expression of growth/differentiation factor 11, a new member of the BMP/TGF-β superfamily during mouse embryogenesis. Mech. Dev. 80:185-89
75. Nishi M, Yasue A, Nishimatu S, Nohno T, Yamaoka T, et al. 2002. A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle. Biochem. Biophys. Res. Commun. 293:247-51
76. Oh SP, Li E. 1997. The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. Genes Dev. 11:1812-26
77. Oh SP, Yeo C-Y, Lee Y, Schrewe H, Whitman M, Li E. 2002. Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning. Genes Dev. 16:2749-54
78. Oliff A, Defeo-Jones D, Boyer M, Martinez D, Kiefer D, et al. 1987. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 50:555-63
79. Ostbye T-K, Galloway TF, Nielsen C, Gabestad I, Bardal T, Andersen O. 2001. The two myostatin genes of Atlantic salmon (Salmo salar) are expressed in a variety of tissues. Eur. J. Biochem. 268:5249-57
80. Pampusch MS, Johnson BJ, White ME, Hathaway MR, Dunn JD, et al. 2003. Time course of changes in growth factor mRNA levels in muscle of steroid-implanted and non-implanted steers. J. Anim. Sci. 81:2733-40
81. Pappano WN, Steiglitz BM, Scott IC, Keene DR, Greenspan DS. 2003. Use of Bmp1/Tll1 doubly homozygous null mice and proteomics to identify and validate in vivo substrates of BMP-1/tolloid-like metalloproteinases. Mol. Cell. Biol. 23:4428-38
82. Peters D, Barash IA, Burdi M, Yuan PS, Mathew L, et al. 2003. Asynchronous functional, cellular and transcriptional changes after a bout of eccentric exercise in the rat. J. Physiol. 553:947-57
83. Piccolo S, Agius E, Lu B, Goodman S, Dale L, DeRobertis EM. 1997. Cleavage of chordin by xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity. Cell 91:407-16
84. Rebbapragada A, Benchabane H, Wrana J, Celeste AJ, Attisano L. 2003. Myostatin signals through a transforming growth factor β-like signaling pathway to block adipogenesis. Mol. Cell. Biol. 23:7230-42
85. Rehemtulla A, Kaufman RJ. 1992. Preferred sequence requirements for cleavage of pro-von Willebrand factor by propeptide-processing enzymes. Blood 79:2349-55
86. Rescan P-Y, Jutel I, Rallière C. 2001. Two myostatin genes are differentially expressed in myotomal muscles of the trout (Oncorhynchus mykiss). J. Exp. Biol. 204:3523-29
87. Ríos R, Carneiro I, Arce VM, Devesa J. 2001. Myostatin regulates cell survival during C2C12 myogenesis. Biochem. Biophys. Res. Comm. 280:561-66
88. Ríos R, Carneiro I, Arce VM, Devesa J. 2002. Myostatin is an inhibitor of myogenic differentiation. Am. J. Physiol. Cell Physiol. 282:C993-99
89. Roberts SB, Goetz FW. 2001. Differential skeletal muscle expression of myostatin across teleost species, and the isolation of multiple myostatin isoforms. FEBS Lett. 24639:1-5
90. Rodgers BD, Weber GM. 2001. Sequence conservation among fish myostatin orthologues and the characterization of two additional cDNA clones from Morone saxatilis and Morone americana. Comp. Biochem. Phys. B 129:597-603
91. Rodgers BD, Weber GM, Kelley KM, Levine MA. 2003. Prolonged fasting and cortisol reduce myostatin mRNA levels in tilapia larvae; short-term fasting elevates. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284:R1277-86
92. Rodgers BD, Weber GM, Sullivan CV, Levine MA. 2001. Isolation and characterization of myostatin complementary deoxyribonucleic acid clones from two commercially important fish: Oreochromis mossambicus and Morone chrysops. Endocrine 142:1412-18
93. Roth SM, Martel GF, Ferrell RE, Metter EJ, Hurley BF, Rogers MA. 2003. Myostatin gene expression is reduced in humans with heavy-resistance strength training: a brief communication. Exp. Biol. Med. (Maywood) 228:706-9
94. Sakuma K, Watanabe K, Sano M, Uramoto I, Totsuka T. 2000. Differential adaptation of growth and differentiation factor 8/myostatin, fibroblast growth factor 6 and leukemia inhibitory factor in overloaded, regenerating and denervated rat muscles. Biochim. Biophys. Acta 1497:77-88
95. Scheufler C, Sebald W, Hülsmeyer M. 1999. Crystal structure of human bone morphogenetic protein-2 at 2.7 Å resolution. J. Mol. Biol. 287:103-15
96. Schier AF, Shen MM. 2000. Nodal signalling in vertebrate development. Nature 403:385-89
97. Schlunegger MP, Grutter MG. 1992. An unusual feature revealed by the crystal structure at 2.2 Å resolution of human transforming growth factor-β2. Nature 358:430-34
98. Schulte JN, Yarasheski KE. 2001. Effects of resistance training on the rate of muscle protein synthesis in frail elderly people. Int. J. Sport Nutr. Exerc. Metab. 11 (Suppl.):S111-18
99. Schultz E, McCormick KM. 1994. Skeletal muscle satellite cells. Rev. Physiol. Biochem. Pharmacol. 123:213-57
100. Scott IC, Blitz IL, Pappano WN, Imamura Y, Clark TG, et al. 1999. Mammalian BMP-1/tolloid-related metalloproteinases, including novel family member mammalian tolloid-like 2, have differential enzymatic activities and distributions of expression relevant to patterning and skeletogenesis. Dev. Biol. 213:283-300
101. Sharma M, Kambadur R, Matthews KG, Somers WG, Devlin GP, et al. 1999. Myostatin, a transforming growth factor-β superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J. Cell. Physiol. 180:1-9
102. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, Barnard PJ. 1989. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244:1578-80
103. Song J, Oh SP, Schrewe H, Nomura M, Lei H, et al. 1999. The type II activin receptors are essential for egg cylinder growth, gastrulation, and rostral head development in mice. Dev. Biol. 213:157-69
104. Stroschein S, Wang W, Zhou S, Zhou Q, Luo K. 1999. Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science 286:771-74
105. Sun Y, Liu X, Ng-Eaton E, Lane WS, Lodish HF, Weinberg RA. 1999a. Interaction of the Ski oncoprotein with Smad3 regulates TGF-β signaling. Mol. Cell 4:499-509
106. Sun Y, Liu X, Ng-Eaton E, Lodish HF, Weinberg RA. 1999b. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor β signaling. Proc. Natl. Acad. Sci. USA 96:12442-47
107. Sutrave P, Kelly AM, Hughes SH. 1990. ski can cause selective growth of skeletal muscle in transgenic mice. Genes Dev. 4:1462-72
108. 12 muscle cells. Am. J. Physiol. Endocrinol. Metab. 280:E221-28
109. Thies RS, Chen T, Davies MV, Tomkinson KN, Pearson AA, et al. 2001. GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding. Growth Factors 18:251-59
110. Thomas M, Langley B, Berry C, Sharma M, Kirk S, et al. 2000. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J. Biol Chem. 275:40235-43
111. Thompson TB, Woodruff TK, Jardetzky TS. 2003. Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-β ligand:receptor interactions. EMBO 122:1555-66
112. Tisdale MJ. 1999. Wasting in cancer. J. Nutr. 129:243S-46S
113. Tseng BS, Zhao P, Pattison JS, Gordon SE, Granchelli JA, et al. 2002. Regenerated mdx mouse skeletal muscle shows differential mRNA expression. J. Appl. Physiol. 93:537-45
114. Tsuchida K, Arai KY, Kuramoto Y, Yamakawa N, Hasegawa Y, Sugino H. 2000. Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-β family. J. Biol. Chem. 275:40788-96
115. Vianello S, Brazzoduro L, Dalla Valle L, Belvedere P, Colombo L. 2003. Myostatin expression during development and chronic stress in zebrafish (Danio rerio). J. Endocrinol. 176:47-59
116. Wagner KR, McPherron AC, Winik N, Lee S-J. 2002. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann. Neurol. 52:832-36
117. Wehling M, Cai B, Tidball JG. 2000. Modulation of myostatin expression during modified muscle use. FASEB J. 14:103-10
118. Welle S, Bhatt K, Shah B, Thornton CA. 2002. Insulin-like growth factor-1 and myostatin mRNA expression in muscle: comparison between 62-77 and 21-31 yr old men. Exp. Gerontol. 37:833-39
119. White ME, Johnson BJ, Hathaway MR, Dayton WR. 2003. Growth factor messenger RNA levels in muscle and liver of steroid-implanted and nonimplanted steers. Anim. Sci. 81:965-72
120. Whittemore L-A, Song K, Li X, Aghajanian J, Davies MV, et al. 2003. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem. Biophys. Res. Commun. 300:965-71
121. Wise RJ, Barr PJ, Wong PA, Kiefer MC, Brake AJ, Kaufman RJ. 1990. Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site. Proc. Natl. Acad. Sci. USA 87:9378-82
122. Wolfman NM, McPherron AC, Pappano WN, Davies MV, Song K, et al. 2003. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc. Natl. Acad. Sci. USA 100:15842-46
123. Yamashita H, ten Dijke P, Huylebroeck D, Sampath TK, Andries M, et al. 1995. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J. Cell Biol. 130:217-26
124. Yang J, Ratovitski T, Brady JP, Solomon MB, Wells KD, Wall RJ. 2001. Expression of myostatin pro domain results in muscular transgenic mice. Mol. Reprod. Dev. 60:351-61
125. Yarasheski K, Bhasin S, Sinha-Hikim I, Pak-Loduca J, Gonzalez-Cadavid N. 2002. Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. J. Nutr. Health Aging 6:343-48
126. Zhu X, Hadhazy M, Wehling M, Tidball JG, McNally EM. 2000. Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett. 474:71-75
127. Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, et al. 2002. Induction of cachexia in mice by systemically administered myostatin. Science 296:1486-88